Consumer group: FDA must ban Avandia because of health risks

10/30/2008 | Washington Post (tiered subscription model), The

Public Citizen, a consumer-advocacy group, called on the FDA to ban GlaxoSmithKline's Avandia because of life-endangering risks, including heart attack and liver failure, linked to the diabetes drug. The agency said it will "carefully review" the petition, which comes after the American Diabetes Association issued revised treatment guidelines that advise against Avandia.

View Full Article in:

Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations